Abstract | PURPOSE: METHOD: RESULTS: The mean interval to treatment was not significantly different (p=0.28) for the dexamethasone group at 5.5 days compared to the methylprednisolone group at 4.1 days. Visual improvement of at least two lines of the Snellen chart or two levels of unmeasured visual acuity was shown in 9 patients (37.5%) of the dexamethasone group and 10 patients (50%) of the methylprednisolone group. There was no statistically significant difference between the initial and post-pulse visual acuity (p=1.0) and the initial and final visual outcome (p=0.60) in the dexamethasone group compared with the methylprednisolone group. CONCLUSION:
|
Authors | Wanicha Chuenkongkaew, Niphon Chirapapaisan |
Journal | Journal of the Medical Association of Thailand = Chotmaihet thangphaet
(J Med Assoc Thai)
Vol. 85
Issue 5
Pg. 597-603
(May 2002)
ISSN: 0125-2208 [Print] Thailand |
PMID | 12188391
(Publication Type: Clinical Trial, Comparative Study, Journal Article, Randomized Controlled Trial)
|
Chemical References |
- Glucocorticoids
- Dexamethasone
- Methylprednisolone
|
Topics |
- Adolescent
- Adult
- Dexamethasone
(administration & dosage)
- Female
- Glucocorticoids
(administration & dosage)
- Humans
- Male
- Methylprednisolone
(administration & dosage)
- Middle Aged
- Optic Nerve Diseases
(drug therapy, physiopathology)
- Prospective Studies
- Treatment Outcome
- Visual Acuity
|